Maci 3CM x 5CM implant sheets
Ended Awarded
- Contract number
- SPE2DB25FZX39
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $61,903
Award facts
- Contract value 100% obligated
- $61,902.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. This firm fixed-price delivery order was awarded on July 14, 2025, with an ultimate completion date of August 4, 2025, and represents no set-aside designation. The award falls under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA under the SPE2DB program, which is valued at $499.999 billion and valid through November 2026, enabling the agency to issue delivery orders for comprehensive pharmaceutical and medical supply needs across military health facilities.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a robust portfolio of contract awards from the Defense Logistics Agency covering an extensive range of medical products including prescription medications, biologics, and medical consumables. The company's consistent performance in delivering specialized pharmaceutical items—ranging from contraceptive devices to oncology treatments and vaccines—to Department of Defense healthcare sites demonstrates its operational capability and reliability as a federal contractor. This delivery order for MACI implant sheets, a regenerative medicine product used in cartilage repair, aligns with the company's established focus on providing specialized medical supplies to military and federal healthcare facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FZX39?
SPE2DB25FZX39 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FZX39 worth?
The government has obligated $61,903 on SPE2DB25FZX39.
Is contract SPE2DB25FZX39 an order under another contract?
Yes. SPE2DB25FZX39 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZX39 competed?
The extent of competition for SPE2DB25FZX39 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award